Chromocell Therapeutics Stock Quote CHRO - Stock Price, News, Charts, Message Board, Trades

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

1.46

Bid

Ask

Volume

88,801

1.1901 Day's Range 1.47

1.06 52 Week Range 6.00

Market Cap

8.419M

Previous Close

1.29

Open

1.26

Last Trade

100

1.46

Last Trade Time

Financial Volume

$ 123,045

VWAP

1.3856

Average Volume (3m)

20,218

Shares Outstanding

5,766,704

Dividend Yield

PE Ratio

-1.14

Earnings Per Share (EPS)

-1.28

Revenue

Net Profit

-7.38M

Chromocell Therapeutics Corporation, a clinical-stage biotech company, focuses on the discovery, development, and commercialization of new therapeutics to alleviate pain. The company intends to selectively target the sodium ion-channel known as NaV1.7, as well as other receptors in the NaV family. I... Chromocell Therapeutics Corporation, a clinical-stage biotech company, focuses on the discovery, development, and commercialization of new therapeutics to alleviate pain. The company intends to selectively target the sodium ion-channel known as NaV1.7, as well as other receptors in the NaV family. Its lead compound comprises CC8464, which is in Phase 2a clinical trials for use in the treatment of erythromelalgia, as well as other fields of neuropathic pain. Chromocell Therapeutics Corporation was founded in 2002 and is based in Freehold, New Jersey. Show more

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

chromocell.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

Chromocell Therapeutics Corporation is listed in the Biological Pds,ex Diagnstics sector of the American Stock Exchange with ticker CHRO. The last closing price for Chromocell Therapeutics was $1.29. Over the last year, Chromocell Therapeutics shares have traded in a share price range of $ 1.06 to $ 6.00.

Chromocell Therapeutics currently has 5,766,704 shares outstanding. The market capitalization of Chromocell Therapeutics is $7.44 million. Chromocell Therapeutics has a price to earnings ratio (PE ratio) of -1.14.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.32	28.0701754386	1.14	1.47	1.07	48724	1.22935716	CS
4	0.1	7.35294117647	1.36	1.48	1.06	29412	1.2280727	CS
12	-0.25	-14.6198830409	1.71	2.76	1.06	20218	1.51549118	CS
26	-4.54	-75.6666666667	6	6	1.06	24461	2.35150467	CS
52	-4.54	-75.6666666667	6	6	1.06	24461	2.35150467	CS
156	-4.54	-75.6666666667	6	6	1.06	24461	2.35150467	CS
260	-4.54	-75.6666666667	6	6	1.06	24461	2.35150467	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
WINTWindtree Therapeutics Inc	$ 8.24 (150.46%)	48.57M
BFIBurgerFi International Inc	$ 0.4206 (97.37%)	313.59M
NBSTWNewbury Street Acquisition Corporation	$ 0.1349 (92.71%)	122.1k
YIBOPlanet Image International Ltd	$ 2.915 (53.43%)	260.07k
CREVCarbon Revolution Public Ltd	$ 9.00 (45.87%)	8.06M
NMHINatures Miracle Holding Inc	$ 0.2035 (-48.06%)	7.69M
TANHTantech Holdings Ltd	$ 0.2585 (-47.23%)	6.75M
DXCMDexCom Inc	$ 64.00 (-40.66%)	53.92M
PSIGPS International Group Ltd	$ 1.42 (-31.40%)	716.26k
POAIPredictive Oncology Inc	$ 1.36 (-27.27%)	6.02M
SLNASelina Hospitality PLC	$ 0.0305 (-18.88%)	408.61M
BFIBurgerFi International Inc	$ 0.4206 (97.37%)	313.59M
NVDANVIDIA Corporation	$ 113.06 (0.69%)	293.33M
SQQQProShares UltraPro Short QQQ	$ 9.10 (-2.88%)	176.49M
SGMOSangamo Therapeutics Inc	$ 0.8612 (28.15%)	123.71M